. Author manuscript; available in PMC: 2017 Apr 15.

Published in final edited form as: J Acquir Immune Defic Syndr. 2016 Apr 15;71(5):570–576. doi: 10.1097/QAI.0000000000000910

Table 3.

Comparison of first and second adequate ACyt results in 856 participants, taken 18–30 months apart, among HIV-infected and uninfected men with no anal squamous intraepithelial lesion treatment

Baseline ACyt	%								P-value
Baseline ACyt	HIV-uninfected				HIV-infected				P-value

	N	Lower grade	Same grade	Higher grade	N	Lower grade	Same grade	Higher grade
Normal	305	--	84%	16%	277	--	71%	29%	<0.001
ASC-US/ LSIL	91	66%	29%	5%	149	56%	29%	15%	0.075
ASC-H / HSIL	13	92%	8%	0%	21	81%	19%	0%	0.364
Overall	409	18%	69%	13%	447	23%	54%	23%	<0.001